
Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was branded the "worst in Europe."
Hughes’ comments came as the company opened a 150 million pounds ($200.16 million) vaccine facility in Oxfordshire.